<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39228900</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>06</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2225-2002</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>African journal of laboratory medicine</Title><ISOAbbreviation>Afr J Lab Med</ISOAbbreviation></Journal><ArticleTitle>Performance comparison of three commercial multiplex molecular panels for respiratory viruses at a South African academic hospital.</ArticleTitle><Pagination><StartPage>2415</StartPage><MedlinePgn>2415</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2415</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.4102/ajlm.v13i1.2415</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Respiratory infections are a major contributor to hospital admissions. Identification of respiratory pathogens by means of conventional culture and serology methods remains challenging. Multiplex molecular assays are an appealing alternative that endeavours to be rapid, more accurate and less arduous.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">The study aimed to compare the clinical performance of three commercial multiplex molecular assays for respiratory viruses.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Forty-eight respiratory specimens obtained from patients at Tygerberg Hospital in the Western Cape province of South Africa were studied. These specimens were collected between May 2020 and August 2020. The results of the Seegene Anyplex™ II RV16, FilmArray<sup>®</sup> Respiratory 2.1 <i>plus</i> Panel (FARP), and QIAstat-Dx<sup>®</sup> Respiratory SARS-CoV-2 Panel (QRP) were analysed based on the overlapping targets. A composite reference standard was applied to provide a standard reference for comparison.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The overall sensitivity of the Seegene Anyplex™ II RV16 was 96.6% (57/59), the FARP 98.2% (56/57) and the QRP 80.7% (46/57). The overall specificities were 99.8% (660/661), 99.0% (704/711) and 99.7% (709/711), respectively. The QRP failed to detect coronaviruses and parainfluenza viruses in 41.7% (5/12) and 28.6% (4/14) of positive specimens, respectively, while the FARP produced the lowest target specificity of 88.4% (38/43) for rhinovirus/enterovirus.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">The overall specificity of all three platforms was comparable; however, the sensitivity of the QRP was inferior to that of the ARV and FARP.</AbstractText><AbstractText Label="WHAT THIS STUDY ADDS" NlmCategory="UNASSIGNED">This study adds to the body of performance characteristics described for respiratory multiplex panels, especially in the African context where molecular diagnostics for infectious diseases are gaining momentum.</AbstractText><CopyrightInformation>© 2024. The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>van der Westhuizen</LastName><ForeName>Clinton</ForeName><Initials>C</Initials><Identifier Source="ORCID">0009-0003-4529-2879</Identifier><AffiliationInfo><Affiliation>Division of Medical Microbiology, Department of Pathology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Microbiology, Tygerberg Hospital, National Health Laboratory Service, Cape Town, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Newton-Foot</LastName><ForeName>Mae</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-3880-8203</Identifier><AffiliationInfo><Affiliation>Division of Medical Microbiology, Department of Pathology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Microbiology, Tygerberg Hospital, National Health Laboratory Service, Cape Town, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nel</LastName><ForeName>Pieter</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-6458-5189</Identifier><AffiliationInfo><Affiliation>Division of Medical Microbiology, Department of Pathology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Microbiology, Tygerberg Hospital, National Health Laboratory Service, Cape Town, South Africa.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>South Africa</Country><MedlineTA>Afr J Lab Med</MedlineTA><NlmUniqueID>101603205</NlmUniqueID><ISSNLinking>2225-2002</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anyplex™ II RV16</Keyword><Keyword MajorTopicYN="N">FilmArray® Respiratory 2.1 plus Panel</Keyword><Keyword MajorTopicYN="N">QIAstat-Dx® Respiratory SARS-CoV-2 Panel</Keyword><Keyword MajorTopicYN="N">composite reference standard</Keyword><Keyword MajorTopicYN="N">molecular panels</Keyword><Keyword MajorTopicYN="N">multiplex reverse transcription polymerase chain reaction</Keyword><Keyword MajorTopicYN="N">respiratory viruses</Keyword></KeywordList><CoiStatement>The authors disclosed that FARP and QRP instruments were provided by bioMérieux® BioFire® and Qiagen®, respectively, for the duration of the study. Kits and reagents used in this study were also sponsored by both manufacturers. Neither bioMérieux® BioFire® nor Qiagen® was involved in the study design, collection, analysis, and interpretation of data, or the writing of the article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>4</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>4</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>4</Day><Hour>4</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39228900</ArticleId><ArticleId IdType="pmc">PMC11369576</ArticleId><ArticleId IdType="doi">10.4102/ajlm.v13i1.2415</ArticleId><ArticleId IdType="pii">AJLM-13-2415</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Templeton KE. Why diagnose respiratory viral infection? J Clin Virol. 2007;40 (Suppl 1): S2–S4. 10.1016/S1386-6532(07)70002-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1386-6532(07)70002-1</ArticleId><ArticleId IdType="pmc">PMC7128291</ArticleId><ArticleId IdType="pubmed">18162250</ArticleId></ArticleIdList></Reference><Reference><Citation>Troeger CE, Blacker BF, Khalil IA, et al. . Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: An analysis for the Global Burden of Disease Study 2017. Lancet Respir Med. 2019;7(1):69–89. 10.1016/S2213-2600(18)30496-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(18)30496-X</ArticleId><ArticleId IdType="pmc">PMC6302221</ArticleId><ArticleId IdType="pubmed">30553848</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabenau HF, Kessler HH, Kortenbusch M, Steinhorst A, Raggam RB, Berger A. Verification and validation of diagnostic laboratory tests in clinical virology. J Clin Virol. 2007;40(2):93–98. 10.1016/j.jcv.2007.07.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2007.07.009</ArticleId><ArticleId IdType="pubmed">17766174</ArticleId></ArticleIdList></Reference><Reference><Citation>Popowitch EB, O’Neill SS, Miller MB. Comparison of the BioFire FilmArray RP, Genmark eSensor RVP, Luminex xTAG RVPv1, and Luminex xTAG RVP fast multiplex assays for detection of respiratory viruses. J Clin Microbiol. 2013;51(5): 1528–1533. 10.1128/jcm.03368-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jcm.03368-12</ArticleId><ArticleId IdType="pmc">PMC3647947</ArticleId><ArticleId IdType="pubmed">23486707</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan M, Koo SH, Jiang B, Lim PQ, Tan TY. Comparison of the Biofire FilmArray Respiratory Panel, Seegene Anyplex II RV16, and Argene for the detection of respiratory viruses. J Clin Virol. 2018;106:13–17. 10.1016/j.jcv.2018.07.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2018.07.002</ArticleId><ArticleId IdType="pmc">PMC7185839</ArticleId><ArticleId IdType="pubmed">30007137</ArticleId></ArticleIdList></Reference><Reference><Citation>Parcina M, Schneider UV, Visseaux B, Jozic R, Hannet I, Lisby JG. Multicenter evaluation of the QIAstat Respiratory Panel – A new rapid highly multiplexed PCR based assay for diagnosis of acute respiratory infections. PLoS One. 2020;15:e0230183. 10.1371/journal.pone.0230183</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0230183</ArticleId><ArticleId IdType="pmc">PMC7067435</ArticleId><ArticleId IdType="pubmed">32163484</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersson ME, Olofsson S, Lindh M. Comparison of the FilmArray assay and in-house real-time PCR for detection of respiratory infection. Scand J Infect Dis. 2014;46(12):897–901. 10.3109/00365548.2014.951681</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00365548.2014.951681</ArticleId><ArticleId IdType="pubmed">25288382</ArticleId></ArticleIdList></Reference><Reference><Citation>Schreckenberger PC, McAdam AJ. Point-counterpoint: Large multiplex PCR panels should be first-line tests for detection of respiratory and intestinal pathogens. J Clin Microbiol. 2015;53(10):3110–3115. 10.1128/JCM.00382-15</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00382-15</ArticleId><ArticleId IdType="pmc">PMC4572537</ArticleId><ArticleId IdType="pubmed">25762770</ArticleId></ArticleIdList></Reference><Reference><Citation>Leber AL, Lisby JG, Hansen G, et al. . Multicenter evaluation of the QIAstat-Dx Respiratory Panel for the detection of viruses and bacteria in nasopharyngeal swab specimens. J Clin Micrbiol. 2020;58(5):e00155-20. 10.1128/JCM.00155-20</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00155-20</ArticleId><ArticleId IdType="pmc">PMC7180242</ArticleId><ArticleId IdType="pubmed">32132186</ArticleId></ArticleIdList></Reference><Reference><Citation>Rappo U, Schuetz AN, Jenkins SG, et al. . Impact of early detection of respiratory viruses by multiplex PCR assay on clinical outcomes in adult patients. J Clin Microbiol. 2016;54(8):2096–2103. 10.1128/JCM.00549-16</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00549-16</ArticleId><ArticleId IdType="pmc">PMC4963510</ArticleId><ArticleId IdType="pubmed">27225406</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen GT, Moore J, Herding E, et al. . Clinical decision making in the emergency department setting using rapid PCR: Results of the CLADE study group. J Clin Virol. 2018;102:42–49. 10.1016/j.jcv.2018.02.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2018.02.013</ArticleId><ArticleId IdType="pmc">PMC7106512</ArticleId><ArticleId IdType="pubmed">29494950</ArticleId></ArticleIdList></Reference><Reference><Citation>Uyeki TM, Bernstein HH, Bradley JS, et al. . Clinical practice guidelines by the Infectious Diseases Society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza. Clin Infect Dis. 2018;68(6):e1–e47. 10.1093/cid/ciy866</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciy866</ArticleId><ArticleId IdType="pmc">PMC6653685</ArticleId><ArticleId IdType="pubmed">30566567</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandenberg O, Martiny D, Rochas O, Van Belkum A, Kozlakidis Z. Considerations for diagnostic COVID-19 tests. Nat Rev Microbiol. 2021;19:171–183. 10.1038/s41579-020-00461-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-020-00461-z</ArticleId><ArticleId IdType="pmc">PMC7556561</ArticleId><ArticleId IdType="pubmed">33057203</ArticleId></ArticleIdList></Reference><Reference><Citation>Da Silva Ferreira BI, Da Silva-Gomes NL, Coelho WLdCNP, et al. . Validation of a novel molecular assay to the diagnostic of COVID-19 based on real time PCR with high resolution melting. PLoS One. 2021;16(11):e0260087. 10.1371/journal.pone.0260087</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0260087</ArticleId><ArticleId IdType="pmc">PMC8608302</ArticleId><ArticleId IdType="pubmed">34807915</ArticleId></ArticleIdList></Reference><Reference><Citation>Naaktgeboren CA, Bertens LCM, Van Smeden M, De Groot JAH, Moons KGM, Reitsma JB. Value of composite reference standards in diagnostic research. BMJ. 2013;347:f5605. 10.1136/bmj.f5605</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.f5605</ArticleId><ArticleId IdType="pubmed">24162938</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonzo TA, Pepe MS. Using a combination of reference tests to assess the accuracy of a new diagnostic test. Stat Med. 1999;18(22):2987–3003. 10.1002/(SICI)1097-0258(19991130)18:22&lt;2987::AID-SIM205&gt;3.0.CO;2-B</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-0258(19991130)18:22&lt;2987::AID-SIM205&gt;3.0.CO;2-B</ArticleId><ArticleId IdType="pubmed">10544302</ArticleId></ArticleIdList></Reference><Reference><Citation>Baughman AL, Bisgard KM, Cortese MM, Thompson WW, Sanden GN, Strebel PM. Utility of composite reference standards and latent class analysis in evaluating the clinical accuracy of diagnostic tests for pertussis. Clin Vaccine Immunol. 2008;15(1):106–114. https://journals.asm.org/doi/10.1128/CVI.00223-07
</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CVI.00223-07</ArticleId><ArticleId IdType="pmc">PMC2223853</ArticleId><ArticleId IdType="pubmed">17989336</ArticleId></ArticleIdList></Reference><Reference><Citation>Seegene® Inc . Anyplex™ II RV16 Detection high multiplex real-time PCR [homepage on the Internet]. No date. 
[cited 2023 Aug 07]. Available from: https://sgarchive.seegene.com/file/manual</Citation></Reference><Reference><Citation>BioFire® Diagnostics, LLC . BioFire® Respiratory Panel 2.1 plus (RP2.1plus) [homepage on the Internet]. c2020 [updated 2022 Jun 03; cited 2023 Aug 07]. Available from: https://www.biofiredx.qarad.eifu.online/ITI/ZA/all?keycode=ITI0019</Citation></Reference><Reference><Citation>Qiagen® GmbH . QIAstat-Dx® Respiratory SARS-CoV-2 Panel instructions for use (Handbook) [homepage on the Internet]. c2020 [updated 2021 Jul; cited 2023 Aug 07]. Available from: https://www.qiagen.com/us/resources/resourcedetail?id=250fafc2-3e66-4400-b5cb-ca69ba8607ab&amp;lang=en</Citation></Reference><Reference><Citation>Simusika P, Bateman AC, Theo A, et al. . Identification of viral and bacterial pathogens from hospitalized children with severe acute respiratory illness in Lusaka, Zambia, 2011–2012: A cross-sectional study. BMC Infect Dis. 2015;15:52. 10.1186/s12879-015-0779-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-015-0779-1</ArticleId><ArticleId IdType="pmc">PMC4391483</ArticleId><ArticleId IdType="pubmed">25888024</ArticleId></ArticleIdList></Reference><Reference><Citation>Moleleki M, Du Plessis M, Ndlangisa K, et al. . Pathogens detected using a syndromic molecular diagnostic platform in patients hospitalized with severe respiratory illness in South Africa in 2017. Int J Infect Dis. 2022;122:389–397. 10.1016/j.ijid.2022.06.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.06.011</ArticleId><ArticleId IdType="pubmed">35700877</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius MA, Madhi SA, Cohen C, et al. . Respiratory viral coinfections identified by a 10-plex real-time reverse-transcription polymerase chain reaction assay in patients hospitalized with severe acute respiratory illness – South Africa, 2009–2010. J Infect Dis. 2012;206(Suppl 1):S159–S165. 10.1093/infdis/jis538</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jis538</ArticleId><ArticleId IdType="pubmed">23169964</ArticleId></ArticleIdList></Reference><Reference><Citation>South African National Accreditation System . TR 28-03 Criteria for validation, verification, uncertainty of measurement and quality assurance in microbiological and molecular testing [homepage on the Internet]. c2014 [updated 2021 Jul 30; cited 2023 Aug 07]. Available from https://www.sanas.co.za/Pages/index.aspx</Citation></Reference><Reference><Citation>Doern CD, Lacey D, Huang R, Haag C. Evaluation and implementation of FilmArray version 1.7 for improved detection of adenovirus respiratory tract infection. J Clin Microbiol. 2013;51(12):4036–4039. 10.1128/JCM.02546-13</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.02546-13</ArticleId><ArticleId IdType="pmc">PMC3838020</ArticleId><ArticleId IdType="pubmed">24068007</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HK, Oh SH, Yun KA, Sung H, Kim MN. Comparison of Anyplex II RV16 with the xTAG respiratory viral panel and Seeplex RV15 for detection of respiratory viruses. J Clin Microbiol. 2013;51(4):1137–1141. 10.1128/JCM.02958-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.02958-12</ArticleId><ArticleId IdType="pmc">PMC3666760</ArticleId><ArticleId IdType="pubmed">23363824</ArticleId></ArticleIdList></Reference><Reference><Citation>Principi N, Bosis S, Esposito S. Effects of coronavirus infections in children. Emerg Infect Dis. 2010;16(2):183–188. 10.3201/eid1602.090469</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1602.090469</ArticleId><ArticleId IdType="pmc">PMC2957994</ArticleId><ArticleId IdType="pubmed">20113545</ArticleId></ArticleIdList></Reference><Reference><Citation>Lebourgeois S, Storto A, Gout B, et al. . Performance evaluation of the QIAstat-Dx Respiratory SARS-CoV-2 Panel. Int J Infect Dis. 2021;107:179–181. 10.1016/j.ijid.2021.04.066</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.04.066</ArticleId><ArticleId IdType="pmc">PMC8064816</ArticleId><ArticleId IdType="pubmed">33901651</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>